Answers are grounded in this paper and cite their sources.
A soluble membrane antigen was isolated from vaginal, vulvar and cervical cancer which reacted with antiserum prepared in a guinea pig against semipurified herpesvirus type 2. In a series of coded experiments, 20 of 21 sera from women with cervical cancer reacted in complement-fixation tests with a soluble membrane antigen from genital cancer cells, while reactions occurred in 5 of 21 sera from matched control women. Neither cancer nor control sera reacted with similar preparations from normal vaginal tissue. Antibody to the virus-induced soluble membrane antigen of cancer tissues appears, therefore, to be more prevalent in the cancer population but is also found in a matched control population.
No takes yet. Share an insight, caveat, or question.
Hollinshead et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: